Among women recruited in the weeks after surgery for non-metastatic BC, CBSM has been shown to reduce depressive symptoms [42], anxiety and negative affect [41] and inflammatory markers including leukocyte gene expression for IL-1β, IL-6, and TNF-α [40]. The gene discussed is IL1B; the disease is breast cancer.